Rituximab in combination with glucocorticoids for treating anti-neutrophil cytoplasmic antibody-associated vasculitis

  • Technology appraisal guidance
  • TA308
  • Published: 

Evidence

Documents containing the evidence that was used to develop the recommendations.

Supporting evidence